Lærke Egefjord

1.0k total citations · 1 hit paper
10 papers, 834 citations indexed

About

Lærke Egefjord is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Lærke Egefjord has authored 10 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in Lærke Egefjord's work include Diabetes Treatment and Management (5 papers), Diet and metabolism studies (3 papers) and Alzheimer's disease research and treatments (2 papers). Lærke Egefjord is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diet and metabolism studies (3 papers) and Alzheimer's disease research and treatments (2 papers). Lærke Egefjord collaborates with scholars based in Denmark, United States and Canada. Lærke Egefjord's co-authors include Jørgen Rungby, Birgitte Brock, Michael Gejl, Albert Gjedde, Kim Vang, Arne Møller, Hans Brændgaard, Hanne Gottrup, Niels Møller and Anders Rodell and has published in prestigious journals such as Scientific Reports, Journal of Cerebral Blood Flow & Metabolism and Alzheimer s & Dementia.

In The Last Decade

Lærke Egefjord

10 papers receiving 826 citations

Hit Papers

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Anal... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
    2016 346 citations Michael Gejl, Albert Gjedde et al. Frontiers in Aging Neuroscience profile →

Peers

Lærke Egefjord
Delin Ma China
Juan Miguel Ruiz‐Albusac Spain
Hassibullah Akeefe United States
Mei Qiu China
S Freude Germany
Guofang Xue China
Verónica Hurtado-Carneiro Spain
Anna C. Schacht Denmark
Piangkwan Sa‐nguanmoo Thailand
Danae Liolitsa United Kingdom
Delin Ma China
Lærke Egefjord
Citations per year, relative to Lærke Egefjord Lærke Egefjord (= 1×) peers Delin Ma

Countries citing papers authored by Lærke Egefjord

Since Specialization
Citations

This map shows the geographic impact of Lærke Egefjord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lærke Egefjord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lærke Egefjord more than expected).

Fields of papers citing papers by Lærke Egefjord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lærke Egefjord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lærke Egefjord. The network helps show where Lærke Egefjord may publish in the future.

Co-authorship network of co-authors of Lærke Egefjord

This figure shows the co-authorship network connecting the top 25 collaborators of Lærke Egefjord. A scholar is included among the top collaborators of Lærke Egefjord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lærke Egefjord. Lærke Egefjord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gejl, Michael, Birgitte Brock, Lærke Egefjord, et al.. (2017). Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment. Scientific Reports. 7(1). 17490–17490. 124 indexed citations
2.
Egefjord, Lærke, Hugo Angleys, Kim Mouridsen, et al.. (2017). Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. Alzheimer s & Dementia. 13(10). 1143–1153. 81 indexed citations
3.
Gejl, Michael, Albert Gjedde, Lærke Egefjord, et al.. (2016). In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Frontiers in Aging Neuroscience. 8. 108–108. 346 indexed citations breakdown →
4.
Gejl, Michael, Lærke Egefjord, Birgitte Brock, et al.. (2013). Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. PubMed. 5. 2–2. 27 indexed citations
5.
Egefjord, Lærke, Michael Gejl, Arne Møller, et al.. (2012). Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.. PubMed. 59(10). A4519–A4519. 70 indexed citations
6.
Gejl, Michael, Lærke Egefjord, Kim Vang, et al.. (2012). Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia. Journal of Cerebral Blood Flow & Metabolism. 32(12). 2146–2152. 41 indexed citations
7.
Bak, Ann Mosegaard, Lærke Egefjord, Michael Gejl, et al.. (2011). Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes. Expert Opinion on Therapeutic Targets. 15(10). 1153–1162. 32 indexed citations
8.
Magnusson, Nils E., et al.. (2010). siRNA‐mediated knock‐down of ZnT3 and ZnT8 affects production and secretion of insulin and apoptosis in INS‐1E cells. Apmis. 119(2). 93–102. 28 indexed citations
9.
Egefjord, Lærke, Andreas Petersen, Ann Mosegaard Bak, & Jørgen Rungby. (2010). Zinc, Alpha Cells and Glucagon Secretion. Current Diabetes Reviews. 6(1). 52–57. 38 indexed citations
10.
Egefjord, Lærke, Jens Ledet Jensen, Claus Heiner Bang‐Berthelsen, et al.. (2009). Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?. BMC Endocrine Disorders. 9(1). 7–7. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Delin Ma Breakdown of academic impact, for papers by Juan Miguel Ruiz‐Albusac Breakdown of academic impact, for papers by Hassibullah Akeefe Breakdown of academic impact, for papers by Mei Qiu Breakdown of academic impact, for papers by S Freude Breakdown of academic impact, for papers by Guofang Xue Breakdown of academic impact, for papers by Verónica Hurtado-Carneiro Breakdown of academic impact, for papers by Anna C. Schacht Breakdown of academic impact, for papers by Piangkwan Sa‐nguanmoo Breakdown of academic impact, for papers by Danae Liolitsa
Rankless by CCL
2026